Literature DB >> 19738227

Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.

Eugenie Koumakis, Julien Wipff, Jerome Avouac, Andre Kahan, Yannick Allanore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738227     DOI: 10.3899/jrheum.090160

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  [Combination of biologics : where do we stand?].

Authors:  P Härle
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

2.  Detection and isolation of auto-reactive human antibodies from primary B cells.

Authors:  Victor G Sendra; Anthony Lie; Gabrielle Romain; Sandeep K Agarwal; Navin Varadarajan
Journal:  Methods       Date:  2013-06-26       Impact factor: 3.608

3.  Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review.

Authors:  Hema Chaplin; Lewis Carpenter; Anni Raz; Elena Nikiphorou; Heidi Lempp; Sam Norton
Journal:  Rheumatology (Oxford)       Date:  2021-08-02       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.